Issues & Perspectives

Pancreatic Cancer Awareness Month

Pancreatic Cancer Awareness Month

Posted by  | Issues & Perspectives, treatment

It’s Pancreatic Cancer Awareness Month, so we wanted to gather our best Kimmel Cancer Center resources for you. Learn more about cancer vaccines and other ways our experts are working to get the immune system to fight pancreatic cancer. Watch leading pancreatic cancer and immunology expert Elizabeth Jaffee, M.D., talk about new work from our(...)

Do you qualify for Social Security disability as a cancer patient? 5 tests

Posted by  | caregiving, Issues & Perspectives, treatment, Uncategorized

Social Security pays benefits for a medical condition that is expected to last for at least a year, or may result in death.  Supplemental Security Income (SSI) supports the aged, blind or disabled who have little or no income, providing cash for basics like food, clothing and shelter. According to social workers at the Johns Hopkins(...)

Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Historic cancer drug approval has roots at Johns Hopkins and its Bloomberg~Kimmel Institute laboratories and clinics

Posted by  | Issues & Perspectives

Breaking news today as, for the first time, a drug has been FDA-approved for cancer based on disease genetics rather than type. Developed from 30 years of basic research at Johns Hopkins and its Bloomberg~Kimmel Institute, pembroluzimab now can be used for colon, pancreatic, stomach, ovarian and other cancers if genetic testing reveals defects in(...)

Lung cancer immunotherapy options expand

Lung cancer immunotherapy options expand

Posted by  | Issues & Perspectives

Patients and doctors received news this week of the FDA’s approval of the immunotherapy drug pembrolizumab in combination with platinum doublet chemotherapy as first-line therapy for all patients with non-small cell lung cancer, irrespective of patients’ tumor PD-L1 status. The new approval follows the FDA’s decision last November to approve pembrolizumab as a first-line therapy for some(...)

Kimmel Cancer Center Joins Nation’s Cancer Centers in Supporting HPV Vaccination

Posted by  | Issues & Perspectives

The Johns Hopkins Kimmel Cancer Center joined all of the nation's cancer centers designated by the National Cancer Institute in endorsing human papillomavirus (HPV) vaccination to prevent cancers caused by the ubiquitous virus. HPV infections are known to cause most cervical, anal, oropharyngeal and other genital cancers. Vaccines are available to prevent infections of certain(...)

The Healing Power of Music

Posted by  | Issues & Perspectives, Uncategorized

I never thought I’d be exposed to such a wide variety of expert musicians and performers working as a communications coordinator in the Cancer Center.  Through the Cancer Center’s Art of Healing Performing Arts Series, I have the exciting opportunity to work with high caliber musicians from the Peabody Institute, local ballet dancers, and even a(...)

More Good News on Melanoma Drug

Posted by  | Issues & Perspectives, Research, treatment

Researchers from the Vanderbilt-Ingram Cancer Center and other institutions reported more data today on studies of a new melanoma drug that target products of a cancer-causing mutation in the BRAF gene. The study, published in the New England Journal of Medicine, tracked patients with metastatic melanoma who have been followed for more than a year(...)